{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:42:34Z","timestamp":1784565754084,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100014584","name":"University Medical Center Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR156\/1"],"award-info":[{"award-number":["TRR156\/1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jdermsci.2017.06.012","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T13:00:35Z","timestamp":1497704435000},"page":"252-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection"],"prefix":"10.1016","volume":"87","author":[{"given":"Pamela Aranda","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Denny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kathrin","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Alflen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Christian","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"von Stebut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Tenzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansj\u00f6rg","family":"Schild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Langguth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus P.","family":"Radsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2017.06.012_bib0005","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2010.09.018","article-title":"Advances in transcutaneous vaccine delivery: do all ways lead to Rome?","volume":"148","author":"Bal","year":"2010","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0010","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1586\/14760584.7.9.1329","article-title":"Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook","volume":"7","author":"Mikszta","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0015","first-page":"808","article-title":"The cost of unsafe injections","volume":"77","author":"Miller","year":"1999","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/36014","article-title":"Skin immunization made possible by cholera toxin","volume":"391","author":"Glenn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0025","article-title":"The skin as an orchestrator of influenza immunity","author":"Stein","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0030","article-title":"Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b\/3 trial","author":"Hung","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0035","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.4049\/jimmunol.174.5.2476","article-title":"Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod","volume":"174","author":"Rechtsteiner","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/jid.2010.254","article-title":"UV exposure boosts transcutaneous immunization and improves tumor immunity: cytotoxic T-cell priming through the skin","volume":"131","author":"Stein","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02686082","article-title":"Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection","volume":"32","author":"Warger","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0050","doi-asserted-by":"crossref","first-page":"e102664","DOI":"10.1371\/journal.pone.0102664","article-title":"Efficacy of imiquimod-based transcutaneous immunization using a nano-dispersed emulsion gel formulation","volume":"9","author":"Stein","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cellimm.2016.06.001","article-title":"Solid nanoemulsion as antigen and immunopotentiator carrier for transcutaneous immunization","volume":"308","author":"Gogoll","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88\u2013dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1074-7613(00)80596-8","article-title":"Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function","volume":"9","author":"Adachi","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0070","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.4049\/jimmunol.159.7.3364","article-title":"Phenotypic and functional characterization of mice that lack the type I receptor for IL-1","volume":"159","author":"Glaccum","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","article-title":"CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs","volume":"99","author":"F\u00f6rster","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0080","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/bmc.1075","article-title":"Development and validation of HPLC method for imiquimod determination in skin penetration studies","volume":"22","author":"Paula","year":"2008","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0085","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.4049\/jimmunol.174.7.3920","article-title":"Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells","volume":"174","author":"Probst","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0090","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/ncomms2566","article-title":"Aldara activates TLR7-independent immune defence","volume":"4","author":"Walter","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0095","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ejcb.2010.04.008","article-title":"Interleukin-1, inflammasomes and the skin","volume":"89","author":"Feldmeyer","year":"2010","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0100","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4049\/jimmunol.180.3.1991","article-title":"Tumor immunotherapy by epicutaneous immunization requires langerhans cells","volume":"180","author":"Stoitzner","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.immuni.2004.06.014","article-title":"CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions","volume":"21","author":"Ohl","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance","volume":"8","author":"F\u00f6rster","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0115","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1084\/jem.185.12.2157","article-title":"On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly\/aly) and spleenless (Hox11(\u2212)\/-) mutant mice","volume":"185","author":"Karrer","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0120","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.4049\/jimmunol.121.4.1262","article-title":"Interactions between viruses and lymphocytes. I. In vivo replication of lymphocytic choriomeningitis virus in mononuclear cells during both chronic and acute viral infections","volume":"121","author":"Doyle","year":"1978","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0125","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/nm.2883","article-title":"Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival","volume":"18","author":"Walter","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1517\/17425247.2013.760542","article-title":"Transcutaneous vaccines \u2013 current and emerging strategies","volume":"10","author":"Hirobe","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0140","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.jaad.2011.11.933","article-title":"A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes","volume":"66","author":"Serra-Guill\u00e9n","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0145","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2230.2002.01151.x","article-title":"Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential","volume":"27","author":"Stanley","year":"2002","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0150","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bdd.1787","article-title":"Comparative transcutaneous immunization with imiquimod-containing ointments and potential of in vitro methods to predict effects","volume":"33","author":"Gogoll","year":"2012","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0155","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.coi.2012.03.008","article-title":"Adjuvants for human vaccines","volume":"24","author":"Alving","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0160","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.immuni.2016.08.010","article-title":"K+ efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria","volume":"45","author":"Gro\u00df","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2017.06.012_bib0165","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/eji.201344094","article-title":"Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T-cell cross-priming","volume":"44","author":"Fehres","year":"2014","journal-title":"Eur. J. Immunol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181117307107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181117307107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T02:16:52Z","timestamp":1692843412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181117307107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0923181117307107"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2017.06.012","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2017.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}